Raynaud's phenomenon as a side effect of chemotherapy with vinblastine and bleomycin for testicular carcinoma.
D000293:Adolescent; D001761:Bleomycin / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011928:Raynaud Disease / Q000139:chemically induced* / Q000188:drug therapy; D013724:Teratoma / Q000188:drug therapy*; D013736:Testicular Neoplasms / Q000188:drug therapy*; D014043:Tolazoline / Q000627:therapeutic use; D014747:Vinblastine / Q000009:adverse effects* / Q000627:therapeutic use
D001761:Bleomycin; D014747:Vinblastine; D014043:Tolazoline